Uganda Testing Injectable HIV Prevention Drug
Your browser doesn’t support HTML5
Ahead of World AIDS Day, Uganda is recruiting women to participate in a trial of an injectable antiretroviral drug to replace Truvada, a daily pill that has low adherence by users. The trial will assess if the new drug - Cabotegravir - can further reduce the risk of acquiring HIV. Halima Athumani has more from Kampala.